<?xml version="1.0" encoding="UTF-8"?>
<p>Infections are the major cause of mobility and mortality in children who are undergoing hematopoietic cell transplantation (HCT) or chemotherapy due to malignancy.
 <xref rid="CIT0001" ref-type="bibr">1</xref>â€“
 <xref rid="CIT0003" ref-type="bibr">3</xref> According to the Center for International Blood and Marrow Transplant Research (CIBMTR), infectious complications were the cause of death in 7% of autologous HCT (auto-HCT), 11% of matched sibling donor HCT (MSD-HCT) and 13% of matched unrelated donor HCT (MUD-HCT) recipients.
 <xref rid="CIT0002" ref-type="bibr">2</xref> Infectious complications in children after HCT were noted in 82% of children after allogeneic HCT (allo-HCT)
 <xref rid="CIT0004" ref-type="bibr">4</xref> and in 21% of children with solid tumor or lymphoma in pediatric auto-HCT setting.
 <xref rid="CIT0005" ref-type="bibr">5</xref> The incidence of viral infection after allo-HCT was observed in 19.3% of patients during the first 30 days after transplantation, 18.5% between 31 and 100 days, and in 20% after day +101 up to 2 years after HCT.
 <xref rid="CIT0004" ref-type="bibr">4</xref> In the auto-HCT setting viral infections were observed only in 11% of patients with median onset of 10 days post-transplant.
 <xref rid="CIT0005" ref-type="bibr">5</xref>
</p>
